Vir Biotechnology Inc (VIR)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -521,960 | -533,344 | -483,040 | -539,437 | -615,117 | -600,747 | -262,022 | -143,740 | 515,837 | 1,142,694 | 1,077,810 | 1,216,116 | 528,584 | -102,319 | -297,356 | -390,336 | -298,665 | -256,787 | -220,492 | -223,253 |
| Total assets | US$ in thousands | 1,398,810 | 1,498,360 | 1,669,560 | 1,793,970 | 1,960,090 | 2,044,900 | 2,243,870 | 2,665,940 | 2,802,090 | 2,695,970 | 2,618,990 | 2,887,130 | 1,954,270 | 1,210,210 | 1,057,580 | 1,135,580 | 918,761 | 943,259 | 672,238 | 477,114 |
| ROA | -37.31% | -35.60% | -28.93% | -30.07% | -31.38% | -29.38% | -11.68% | -5.39% | 18.41% | 42.39% | 41.15% | 42.12% | 27.05% | -8.45% | -28.12% | -34.37% | -32.51% | -27.22% | -32.80% | -46.79% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $-521,960K ÷ $1,398,810K
= -37.31%
The return on assets (ROA) is a key financial ratio that indicates a company's efficiency in generating earnings from its assets. Based on the data provided for Vir Biotechnology Inc, the ROA fluctuated over the analyzed period.
From March 31, 2020, to December 31, 2021, the ROA remained predominantly negative, indicating that the company was not effectively utilizing its assets to generate profits. However, starting in March 31, 2022, there was a significant improvement in ROA, turning positive and reaching its peak at 42.39% on September 30, 2022.
After that peak, the ROA started to decline in subsequent periods, eventually becoming negative again by December 31, 2023. The decreasing trend continued through December 31, 2024, with the ROA showing a decline to -37.31%. This negative trend towards the end of the period may suggest challenges in asset efficiency and profitability for Vir Biotechnology Inc.
Overall, the analysis of ROA for Vir Biotechnology Inc indicates significant fluctuations, with periods of both positive and negative ROA figures, highlighting the importance of consistently monitoring and managing asset utilization to drive profitability and financial performance.
Peer comparison
Dec 31, 2024